医学
上市后监督
不良事件报告系统
药物警戒
不利影响
环境卫生
药品审批
营销
医疗急救
药理学
药品
业务
作者
Xiang Fu,Dongqiang Zeng,Min Li,Jian Wu,Yufan Yang,Qianqian Mao,Wenjun Qiu,Xiatong Huang,Yiran Fang,Luyang Jiang,Panwei Hu,Jiani Wu,Wangjun Liao,Jiani Wu,Wangjun Liao
标识
DOI:10.1080/14740338.2025.2471512
摘要
This investigation offered novel prospects for monitoring and addressing undesirable medication effects associated with amivantamab, which might improve the clinical medication safety.
科研通智能强力驱动
Strongly Powered by AbleSci AI